Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Canakinumab bulk supplier for pharma manufacturers

Canakinumab 150 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 150 mg/mL

Reference Brands: Ilaris (USA/EU)

Category: Immune Disorder

Canakinumab is a monoclonal antibody that targets interleukin-1β to reduce inflammation in various autoinflammatory disorders. It is used for conditions such as CAPS, Still’s disease, gout flares, and certain periodic fever syndromes. The drug is administered subcutaneously in controlled doses according to the specific indication.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Canakinumab — third party manufacturing & bulk supply

Canakinumab 150 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Canakinumab is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Canakinumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Canakinumab →
Back to Listing

Frequently Asked Questions

Canakinumab is used to treat several inflammatory conditions such as Cryopyrin-Associated Periodic Syndromes (CAPS), Familial Mediterranean Fever (FMF), Still’s disease, and certain forms of gouty arthritis. It works by blocking interleukin-1β, a key mediator of inflammation.

Canakinumab is made from a fully human monoclonal antibody specifically designed to neutralize interleukin-1β and reduce inflammation in the body.

The commonly known trade name is Ilaris.

Ilaris is manufactured and marketed by Novartis Pharmaceuticals.

The generic name is canakinumab.

The well-known brand name is Ilaris.

Canakinumab is manufactured in various Novartis facilities located in Switzerland, the USA, and other regulated global manufacturing regions.

Related Products

Etrasimod Arginine

Strength:
2 mg, 4 mg, 6 mg

Form: Tablets

Reference Brands: Velsipity (USA)

View Details
Avacopan

Strength:
10 mg

Form: Capsules

Reference Brands: Tavneos (USA/EU)

View Details
Fostamatinib Disodium

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Tavalisse (USA)

View Details
Deucravacitinib

Strength:
6 mg

Form: Tablet

Reference Brands: Sotyktu (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.